Sign In
Buy GKOS
$113.64
+2.86 (+2.58%)
At Close: Jun 03, 2026
Glaukos (GKOS) Down 45.8% Since Last Earnings Report: Can It Rebound?
03:30pm, Saturday, 28'th Mar 2020
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Glaukos Corp (NYSE:GKOS) Stake Increased by Credit Suisse AG
11:33am, Saturday, 28'th Mar 2020
Credit Suisse AG increased its stake in Glaukos Corp (NYSE:GKOS) by 42.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 36,818 shares of the medical instruments sup
Advisor Group Inc. Grows Stock Holdings in Glaukos Corp (NYSE:GKOS)
08:18am, Thursday, 26'th Mar 2020
Advisor Group Inc. raised its stake in Glaukos Corp (NYSE:GKOS) by 9.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 6,710 shares of the medical instruments suppl
BRIEF-Glaukos Corp Withdraws Its Previously Announced Q1 And Annual Guidance For 2020
01:21pm, Tuesday, 24'th Mar 2020
Glaukos Corp:
Glaukos Provides COVID-19 Pandemic Update
01:00pm, Tuesday, 24'th Mar 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retina diseases, today pro
Glaukos Corp (NYSE:GKOS) Holdings Lifted by ProShare Advisors LLC
09:04am, Tuesday, 24'th Mar 2020
ProShare Advisors LLC boosted its position in shares of Glaukos Corp (NYSE:GKOS) by 28.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The ins
Edited Transcript of GKOS earnings conference call or presentation 27-Feb-20 9:30pm GMT
06:19am, Tuesday, 24'th Mar 2020
Q4 2019 Glaukos Corp Earnings Call
Glaukos (GKOS) Gets a Buy Rating from Stephens
07:06pm, Monday, 23'rd Mar 2020
Stephens analyst Chris Cooley maintained a Buy rating on Glaukos (GKOS) today and set a price target of $44.00. The company's shares closed last Monday at
Glaukos (GKOS) Gets a Buy Rating from Stephens
07:06pm, Monday, 23'rd Mar 2020
Stephens analyst Chris Cooley maintained a Buy rating on Glaukos (GKOS – Research Report) today and set a price target
Edited Transcript of GKOS earnings conference call or presentation 27-Feb-20 9:30pm GMT
04:27pm, Monday, 23'rd Mar 2020
Q4 2019 Glaukos Corp Earnings Call
Citigroup Inc. Decreases Stock Holdings in Glaukos Corp (NYSE:GKOS)
10:02am, Saturday, 21'st Mar 2020
Citigroup Inc. trimmed its position in shares of Glaukos Corp (NYSE:GKOS) by 36.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Th
Glaukos (NYSE:GKOS) Downgraded to Buy at ValuEngine
06:58am, Friday, 20'th Mar 2020
Glaukos (NYSE:GKOS) was downgraded by investment analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Friday, ValuEngine
Is Glaukos Corporation’s (NYSE:GKOS) 2.3% ROE Worse Than Average?
11:39am, Thursday, 19'th Mar 2020
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Glaukos (NYSE:GKOS) Stock Price Up 7.7%
09:20am, Thursday, 19'th Mar 2020
Glaukos Corp (NYSE:GKOS) shot up 7.7% on Tuesday . The stock traded as high as $37.14 and last traded at $35.92, 1,614,078 shares traded hands during mid-day trading. An increase of 78% from the avera
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
